Cargando…

Notch3 inhibits epithelial–mesenchymal transition by activating Kibra-mediated Hippo/YAP signaling in breast cancer epithelial cells

Invasion, metastasis and chemoresistance are leading causes of death in breast cancer patients. A vital change of epithelial cells, epithelial–mesenchymal transition (EMT), is involved in these processes. Unfortunately, the molecular mechanisms controlling EMT remain to be elucidated. Our previous s...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhang, X, Liu, X, Luo, J, Xiao, W, Ye, X, Chen, M, Li, Y, Zhang, G-J
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group 2016
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5141289/ https://www.ncbi.nlm.nih.gov/pubmed/27841855 http://dx.doi.org/10.1038/oncsis.2016.67

Ejemplares similares

WWC3 inhibits epithelial–mesenchymal transition of lung cancer by activating Hippo-YAP signaling
por: Han, Qiang, et al.
Publicado: (2018)

GABAB receptor inhibits tumor progression and epithelial-mesenchymal transition via the regulation of Hippo/YAP1 pathway in colorectal cancer
por: Wang, Huihui, et al.
Publicado: (2021)

The Regulatory Role of KIBRA and PTPN14 in Hippo Signaling and Beyond
por: Wilson, Kayla E., et al.
Publicado: (2016)

Kibra Is a Regulator of the Salvador/Warts/Hippo Signaling Network
por: Genevet, Alice, et al.
Publicado: (2010)

SOX9 promotes epithelial-mesenchymal transition via the Hippo-YAP signaling pathway in gastric carcinoma cells
por: Zhou, Hailang, et al.
Publicado: (2019)

Twist-mediated Epithelial-mesenchymal Transition Promotes Breast Tumor Cell Invasion via Inhibition of Hippo Pathway
por: Wang, Yifan, et al.
Publicado: (2016)

DACH1 inhibits SNAI1-mediated epithelial–mesenchymal transition and represses breast carcinoma metastasis
por: Zhao, F, et al.
Publicado: (2015)

Radiation driven epithelial-mesenchymal transition is mediated by Notch signaling in breast cancer
por: Kim, Rae-Kwon, et al.
Publicado: (2016)

Sorafenib ameliorates bleomycin-induced pulmonary fibrosis: potential roles in the inhibition of epithelial–mesenchymal transition and fibroblast activation
por: Chen, Y-L, et al.
Publicado: (2013)

Upregulation of CD109 Promotes the Epithelial-to-Mesenchymal Transition and Stemness Properties of Lung Adenocarcinomas via Activation of the Hippo-YAP Signaling
por: Lee, Kang-Yun, et al.
Publicado: (2020)

Role of fucosyltransferase IV in epithelial–mesenchymal transition in breast cancer cells
por: Yang, X, et al.
Publicado: (2013)

Pin1/YAP pathway mediates matrix stiffness‐induced epithelial–mesenchymal transition driving cervical cancer metastasis via a non‐Hippo mechanism
por: Yang, Long, et al.
Publicado: (2022)

Negative feedback couples Hippo pathway activation with Kibra degradation independent of Yorkie-mediated transcription
por: Tokamov, Sherzod A, et al.
Publicado: (2021)

A “NOTCH” Deeper into the Epithelial-To-Mesenchymal Transition (EMT) Program in Breast Cancer
por: Kar, Rohan, et al.
Publicado: (2019)

The Hippo Pathway Effector YAP1 Regulates Intestinal Epithelial Cell Differentiation
por: Fallah, Sepideh, et al.
Publicado: (2020)

3,6-dihydroxyflavone suppresses the epithelial-mesenchymal transition in breast cancer cells by inhibiting the Notch signaling pathway
por: Chen, Junli, et al.
Publicado: (2016)

Src family kinases inhibit differentiation of intestinal epithelial cells through the Hippo effector YAP1
por: Fallah, Sepideh, et al.
Publicado: (2021)

Relaxin inhibits cardiac fibrosis and endothelial–mesenchymal transition via the Notch pathway
por: Zhou, X, et al.
Publicado: (2015)

The epigenetic modifier trichostatin A, a histone deacetylase inhibitor, suppresses proliferation and epithelial–mesenchymal transition of lens epithelial cells
por: Chen, X, et al.
Publicado: (2013)

MiR-195 suppresses the metastasis and epithelial–mesenchymal transition of hepatocellular carcinoma by inhibiting YAP
por: Yu, Shuo, et al.
Publicado: (2017)

Notch3 Transactivates Glycogen Synthase Kinase-3-Beta and Inhibits Epithelial-to-Mesenchymal Transition in Breast Cancer Cells
por: Chen, Weiling, et al.
Publicado: (2022)

Physical Interaction between HPV16E7 and the Actin-Binding Protein Gelsolin Regulates Epithelial-Mesenchymal Transition via HIPPO-YAP Axis
por: Matarrese, Paola, et al.
Publicado: (2021)

Inhibitor of DNA Binding 2 Inhibits Epithelial-Mesenchymal Transition via Up-Regulation of Notch3 in Breast Cancer
por: Wen, Xiao-Fen, et al.
Publicado: (2018)

Hippo transducer TAZ promotes epithelial mesenchymal transition and supports pancreatic cancer progression
por: Xie, Dacheng, et al.
Publicado: (2015)

Emodin inhibiting neutrophil elastase‐induced epithelial‐mesenchymal transition through Notch1 signalling in alveolar epithelial cells
por: Zhou, Linshui, et al.
Publicado: (2020)

Expression of YAP in endometrial carcinoma tissues and its effect on epithelial to mesenchymal transition
por: Cheng, Yun, et al.
Publicado: (2020)

Regorafenib inhibits epithelial-mesenchymal transition and suppresses cholangiocarcinoma metastasis via YAP1-AREG axis
por: Chang, Yu-Chan, et al.
Publicado: (2022)

Silibinin inhibits the migration, invasion and epithelial-mesenchymal transition of prostate cancer by activating the autophagic degradation of YAP
por: Dan, Weichao, et al.
Publicado: (2022)

Notch1 signaling regulates the epithelial–mesenchymal transition and invasion of breast cancer in a Slug-dependent manner
por: Shao, Shan, et al.
Publicado: (2015)

The essential role of YAP in ERα36-mediated proliferation and the epithelial-mesenchymal transition in MCF-7 breast cancer cells
por: Park, Miso, et al.
Publicado: (2022)

c-Met and CREB1 are involved in miR-433-mediated inhibition of the epithelial–mesenchymal transition in bladder cancer by regulating Akt/GSK-3β/Snail signaling
por: Xu, X, et al.
Publicado: (2016)

Cyclin G2 inhibits epithelial-to-mesenchymal transition by disrupting Wnt/β-catenin signaling
por: Bernaudo, S, et al.
Publicado: (2016)

Notch signaling: targeting cancer stem cells and epithelial-to-mesenchymal transition
por: Espinoza, Ingrid, et al.
Publicado: (2013)

NUMB negatively regulates the epithelial-mesenchymal transition of triple-negative breast cancer by antagonizing Notch signaling
por: Zhang, Jianchao, et al.
Publicado: (2016)

IKBKE regulates cell proliferation and epithelial–mesenchymal transition of human malignant glioma via the Hippo pathway
por: Lu, Jie, et al.
Publicado: (2017)

The Tumor Suppressor CYLD Inhibits Mammary Epithelial to Mesenchymal Transition by the Coordinated Inhibition of YAP/TAZ and TGFβ Signaling
por: Pseftogas, Athanasios, et al.
Publicado: (2020)

Glucose promotes epithelial‐mesenchymal transitions in bladder cancer by regulating the functions of YAP1 and TAZ
por: Li, Shi, et al.
Publicado: (2020)

Notch3 inhibits epithelial–mesenchymal transition in breast cancer via a novel mechanism, upregulation of GATA-3 expression
por: Lin, Hao-Yu, et al.
Publicado: (2018)

Fluid shear stress activates YAP to promote epithelial–mesenchymal transition in hepatocellular carcinoma
por: Yu, Hongchi, et al.
Publicado: (2021)

Exploring YAP1-centered networks linking dysfunctional CFTR to epithelial–mesenchymal transition
por: Quaresma, Margarida C, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_lsgool6ndh7aupe2iu9ktuv93n